Remicade Biosimilar Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Choose License

Report Code: ZMR-2197 | Report Format : | Status : Upcoming |

Abstract

Remicade Biosimilar Market: Overview

Biosimilar is a term that is used to define a biological product type that is very much similar to the drug that is already approved by the FDA; this product is known as the reference biological product. The Remicade is an antibody that is monoclonal and is used for the treatment of the Crohn’s disease in the patients. 

Remicade Biosimilar Market: Facts

The US FDA approved the Renflexis manufactured by the Samsung Bioepis. It is the infliximab biosimilar product infliximab-abda that is used for the multiple indications. It is the second FDA-approved biosimilar product. Remicade manufactured by Janssen Biotech Inc. was the reference product. The US FDA had approved Inflectra from Celltrion in the year 2016.

Remicade Biosimilar Market: Segmentation

The market for the Remicade biosimilar is fragmented into its disease indication and regions. On the basis of the indication of the diseases, the market is segregated into rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn’s disease, ankylosing spondylitis, and ulcerative colitis. Depending on the geographical regions, the market for the macadamia is divided into Latin America, Western Europe, the Middle East & Africa, North America, Eastern Europe, and Asia Pacific.

Remicade Biosimilar Market: Growth Factors

The factors that are driving the Remicade biosimilar market are the early expiry of the patents of the branded version, speedy reaction times owing to the intravenous mode of administration, increasing cases of the autoimmune diseases especially rheumatoid arthritis and plaque psoriasis, and the discounted pricing. The entry of the biosimilar version will improve the accessibility of the patients to the medicines and will also provide financial relief. There are factors that will restrain the growth of the market which include the side effects that are caused by the drug may be fatal and can lead to hospitalization. Others factors that are affecting the market growth are shortage of the FDA approved facilities that are required for the production of the drugs and the complex nature of the molecule.

Remicade Biosimilar Market: Regional Analysis

The region that is leading in the Remicade biosimilar market is Europe and the regions that are following are Latin America and Asia Pacific. The key reason that is driving the market in these regions is the introduction of the biosimilar version shortly after the patent expiry of the version that was branded. The speedy drug review process and the systematic approach towards the drug discovery will develop the revenue development in the regions of North America. In the Central and the South America there are strict laws for the approval procedures and stringent guidelines for the manufacturing of the drugs thus leading to the chances of developing strategies for the regional manufacturing and distribution of the Remicade biosimilars.

Remicade Biosimilar Market: Competitive Players

The key market players that are involved in the Remicade biosimilar market include Merck &Co., Celltrion Inc., Napp Pharmaceuticals, Janssen Biotech Inc., Pfizer Inc., Alvogen, and Nippon Kayaku.

Remicade Biosimilar Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Healthcare M2M Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2632 | Report Format:

Global Healthcare M2M Market: Overview Machine-to-machine (M2M) technology is an extremely significant tool in the healthcare sector. Medical devices can enhance patient care skills and provide remote diagnostics, it can change health care in a lot of manners such as it needs a small quantity of...Read More

Healthcare IT Outsourcing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2630 | Report Format:

Global Healthcare IT Outsourcing Market: Overview Outsourcing can be referred as the method in which a company chooses the most proficient third party to provide some selected services such as operational management, administrative services or data management. The healthcare industry is in its r...Read More

Intraocular Lens Market, by Type (Monofocal IOLs and Premium IOLs); By Application (Cataract Surgery, Refractive Lens Exchange Surgery, and Trauma Surgery); By Material (Polymethylmethacrylate (PMMA), Silicon, Hydrophobic Acrylic, and Hydrogel); By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Ophthalmology Clinics, and Eye Research Institutes): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2022

Feb-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2627 | Report Format:

Report Brief The report covers the forecast and analysis of the intraocular lens market on the global as well as regional level The report incorporates the positive and the negative factors that are affecting the growth of the market The market opportunities are discussed in detail in the repo...Read More

Rheumatology Therapeutics Market by Disease Type (Rheumatoid Arthritis, Osteoarthritis, Lupus, Gout, Ankylosing spondylitis and other), Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids and Others), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022.: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022

Feb-2018 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2616 | Report Format:

The report covers forecast and analysis for the rheumatology therapeutics market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the rheumatology thera...Read More

ePharmacy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2604 | Report Format:

Global ePharmacy Market: Overview The ePharmacy, also popularly known as online pharmacy, or mail-order pharmacy, or Internet pharmacy, is a pharmacy operating via Internet and does the sending of orders to its customers via shipping companies or mail. ePharmacies include pharmacy benefit manage...Read More

Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.

Quick Inquiry